BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eriksson D, Goldsmith D, Teitsson S, Jackson J, van Nooten F. Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia. BMC Nephrol 2016;17:97. [PMID: 27460779 DOI: 10.1186/s12882-016-0312-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Jensen G, Gøransson LG, Fernström A, Furuland H, Christensen JH. Treatment of iron deficiency in patients with chronic kidney disease: A prospective observational study of iron isomaltoside (NIMO Scandinavia)
. Clin Nephrol 2019;91:246-53. [PMID: 30614439 DOI: 10.5414/CN109474] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data. BMC Nephrol 2020;21:88. [PMID: 32143582 DOI: 10.1186/s12882-020-01746-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
3 Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, Małyszko J, Swinkels DW, Tarng DC, Cheung M, Jadoul M, Winkelmayer WC, Drüeke TB; Conference Participants. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int 2021;99:1280-95. [PMID: 33839163 DOI: 10.1016/j.kint.2021.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abberton M, Paliwal R, Faloye B, Marimagne T, Moriam A, Oyatomi O. Indigenous African Orphan Legumes: Potential for Food and Nutrition Security in SSA. Front Sustain Food Syst 2022;6:708124. [DOI: 10.3389/fsufs.2022.708124] [Reference Citation Analysis]
5 Shibata T, Nomura Y, Takada A, Ueno M, Katashima M, Yazawa R, Furihata K. Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects. Clin Pharmacol Drug Dev 2019;8:304-13. [PMID: 29966038 DOI: 10.1002/cpdd.597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
6 Wang Y, Wei RB, Su TY, Huang MJ, Li P, Chen XM. Clinical and pathological factors of renal anaemia in patients with IgA nephropathy in Chinese adults: a cross-sectional study. BMJ Open 2019;9:e023479. [PMID: 30647035 DOI: 10.1136/bmjopen-2018-023479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
7 Goldsmith D, Dellanna F, Schiestl M, Krendyukov A, Combe C. Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience? Clin Drug Investig 2018;38:481-90. [PMID: 29500617 DOI: 10.1007/s40261-018-0637-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
8 Grandy S, Palaka E, Guzman N, Dunn A, Wittbrodt ET, Finkelstein FO. Understanding Patient Perspectives of the Impact of Anemia in Chronic Kidney Disease: A United States Patient Survey. Journal of Patient Experience 2022;9:237437352210926. [DOI: 10.1177/23743735221092629] [Reference Citation Analysis]
9 Borawski B, Malyszko JS, Kwiatkowska M, Malyszko J. Current Status of Renal Anemia Pharmacotherapy-What Can We Offer Today. J Clin Med 2021;10:4149. [PMID: 34575261 DOI: 10.3390/jcm10184149] [Reference Citation Analysis]
10 Zheng L, Tian J, Liu D, Zhao Y, Fang X, Zhang Y, Liu Y. Efficacy and safety of roxadustat for anaemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A systematic review and meta-analysis. Br J Clin Pharmacol 2021. [PMID: 34428860 DOI: 10.1111/bcp.15055] [Reference Citation Analysis]
11 Zheng X, Chen X, Liu T, Jiang J, Cui X, Zhao Q, Hu P. Liquid chromatography-tandem mass spectrometry methods for quantification of roxadustat (FG-4592) in human plasma and urine and the applications in two clinical pharmacokinetic studies. Journal of Chromatography B 2022. [DOI: 10.1016/j.jchromb.2022.123274] [Reference Citation Analysis]
12 Pergola PE, Pecoits-Filho R, Winkelmayer WC, Spinowitz B, Rochette S, Thompson-Leduc P, Lefebvre P, Shafai G, Bozas A, Sanon M, Krasa HB. Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review. Pharmacoecon Open 2019;3:463-78. [PMID: 30968369 DOI: 10.1007/s41669-019-0132-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
13 Hoshino J, Muenz D, Zee J, Sukul N, Speyer E, Guedes M, Lopes AA, Asahi K, van Haalen H, James G, Dhalwani N, Pecoits-filho R, Bieber B, Robinson BM, Pisoni RL, Lopes A, Pecoits-filho R, Combe C, Jacquelinet C, Massy Z, Stengel B, Duttlinger J, Fliser D, Lonnemann G, Reichel H, Wada T, Yamagata K, Pisoni R, Robinson B, Calice da Silva V, Sesso R, Speyer E, Asahi K, Hoshino J, Narita I, Perlman R, Port F, Sukul N, Wong M, Young E, Zee J. Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD. Journal of Renal Nutrition 2020;30:404-14. [DOI: 10.1053/j.jrn.2019.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Mehta R, Cai X, Hodakowski A, Lee J, Leonard M, Ricardo A, Chen J, Hamm L, Sondheimer J, Dobre M, David V, Yang W, Go A, Kusek JW, Feldman H, Wolf M, Isakova T; CRIC Study Investigators. Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. Clin J Am Soc Nephrol 2017;12:1795-803. [PMID: 28784656 DOI: 10.2215/CJN.03950417] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 5.4] [Reference Citation Analysis]
15 Gaipov A, Issanov A, Mursalova Z, Tulegenova N, Kakim Z, Baizakov M, Tuganbekova S, Aljofan M. Dose equivalency and efficacy of biosimilar erythropoietin stimulating agents: Data from real clinical practice. Pharmacol Res Perspect 2020;8:e00594. [PMID: 32524766 DOI: 10.1002/prp2.594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Dai S, Chen Y, Hao C, Ge X, Xie Q, Shang D, Zhu T. Addition of roxadustat to erythropoiesis-stimulating agent (ESA) effectively corrects ESA-hyporesponsive anaemia in patients on peritoneal dialysis. J Clin Pharm Ther 2022. [PMID: 35633100 DOI: 10.1111/jcpt.13696] [Reference Citation Analysis]
17 Haalen HV, Sloand J, Moon R, Palaka E, Milligan G, Allum A, Jackson J. Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: Cross sectional analysis of real-world data. Kidney Res Clin Pract 2020;39:318-33. [PMID: 32958723 DOI: 10.23876/j.krcp.20.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Herdman M, Kerr C, Pavesi M, Garside J, Lloyd A, Cubi-Molla P, Devlin N. Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. J Patient Rep Outcomes 2020;4:22. [PMID: 32219576 DOI: 10.1186/s41687-020-0185-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hussain S, Habib A, Najmi AK. Anemia prevalence and its impact on health-related quality of life in Indian diabetic kidney disease patients: Evidence from a cross-sectional study. J Evid Based Med 2019;12:243-52. [PMID: 31769220 DOI: 10.1111/jebm.12367] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
20 Kim JH, Han JM, Kim H, Lee KB, Chung W, Kim YS, Park SK, Chae DW, Ahn C, Oh KH, Hyun YY; KNOW-CKD Study Group. Low serum adiponectin level is associated with better physical health-related quality of life in chronic kidney disease. Sci Rep 2021;11:10928. [PMID: 34035377 DOI: 10.1038/s41598-021-90339-8] [Reference Citation Analysis]
21 Schmidt C, Allen S, Kopyt N, Pergola P. Iron Replacement Therapy with Oral Ferric Maltol: Review of the Evidence and Expert Opinion. J Clin Med 2021;10:4448. [PMID: 34640466 DOI: 10.3390/jcm10194448] [Reference Citation Analysis]
22 Nöhre M, Pollmann I, Mikuteit M, Weissenborn K, Gueler F, de Zwaan M. Partnership Satisfaction in Living Kidney Donors. Front Psychiatry 2018;9:353. [PMID: 30123146 DOI: 10.3389/fpsyt.2018.00353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Gould DW, Doidge J, Sadique MZ, Borthwick M, Hatch R, Caskey FJ, Forni L, Lawrence RF, MacEwen C, Ostermann M, Mouncey PR, Harrison DA, Rowan KM, Young JD, Watkinson PJ. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study. Health Technol Assess 2022;26:1-58. [PMID: 35212260 DOI: 10.3310/ZXHI9396] [Reference Citation Analysis]
24 Adera H, Hailu W, Adane A, Tadesse A. Prevalence Of Anemia And Its Associated Factors Among Chronic Kidney Disease Patients At University Of Gondar Hospital, Northwest Ethiopia: A Hospital-Based Cross Sectional Study. Int J Nephrol Renovasc Dis 2019;12:219-28. [PMID: 31686891 DOI: 10.2147/IJNRD.S216010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Spinowitz B, Pecoits-Filho R, Winkelmayer WC, Pergola PE, Rochette S, Thompson-Leduc P, Lefebvre P, Shafai G, Bozas A, Sanon M, Krasa HB. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. J Med Econ 2019;22:593-604. [PMID: 30813807 DOI: 10.1080/13696998.2019.1588738] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
26 Gould DW, Doidge J, Zia Sadique M, Borthwick M, Caskey FJ, Forni L, Lawrence RF, Macewen C, Mouncey PR, Ostermann M, Harrison DA, Rowan KM, Duncan Young J, Watkinson PJ. Renal replacement anticoagulant management: Protocol and analysis plan for an observational comparative effectiveness study of linked data sources. Journal of the Intensive Care Society. [DOI: 10.1177/1751143720913417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Covic A, Jackson J, Hadfield A, Pike J, Siriopol D. Real-World Impact of Cardiovascular Disease and Anemia on Quality of Life and Productivity in Patients with Non-Dialysis-Dependent Chronic Kidney Disease. Adv Ther 2017;34:1662-72. [PMID: 28578500 DOI: 10.1007/s12325-017-0566-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
28 Kalra PA, Bhandari S, Spyridon M, Davison R, Lawman S, Mikhail A, Reaich D, Pritchard N, McCafferty K, Moore J. NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease. BMC Nephrol 2020;21:539. [PMID: 33302891 DOI: 10.1186/s12882-020-02180-2] [Reference Citation Analysis]
29 Locatelli F, Del Vecchio L. Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients? J Nephrol 2017;30:755-65. [PMID: 28717990 DOI: 10.1007/s40620-017-0421-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
30 Groenendaal-van de Meent D, den Adel M, van Dijk J, Barroso-Fernandez B, El Galta R, Golor G, Schaddelee M. Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects. Eur J Drug Metab Pharmacokinet 2018;43:685-92. [PMID: 29752643 DOI: 10.1007/s13318-018-0480-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
31 Del Vecchio L, Locatelli F. Roxadustat in the treatment of anaemia in chronic kidney disease. Expert Opin Investig Drugs. 2018;27:125-133. [PMID: 29254377 DOI: 10.1080/13543784.2018.1417386] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
32 Yang F, Wong CKH, Luo N, Piercy J, Moon R, Jackson J. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis. Eur J Health Econ 2019;20:1195-206. [PMID: 31338698 DOI: 10.1007/s10198-019-01088-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
33 Carlson J, Gerson AC, Matheson MB, Manne S, Warady BA, Hooper SR, Lande M, Harshman LA, Johnson RJ, Shinnar S, Kogon AJ, Furth S. A longitudinal analysis of the effect of anemia on health-related quality of life in children with mild-to-moderate chronic kidney disease. Pediatr Nephrol 2020;35:1659-67. [PMID: 32333284 DOI: 10.1007/s00467-020-04569-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Surendra NK, Abdul Manaf MR, Hooi LS, Bavanandan S, Mohamad Nor FS, Shah Firdaus Khan S, Ong LM, Abdul Gafor AH. Health related quality of life of dialysis patients in Malaysia: Haemodialysis versus continuous ambulatory peritoneal dialysis. BMC Nephrol 2019;20:151. [PMID: 31039745 DOI: 10.1186/s12882-019-1326-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
35 Hao CM, Wittbrodt ET, Palaka E, Guzman N, Dunn A, Grandy S. Understanding Patient Perspectives and Awareness of the Impact and Treatment of Anemia with Chronic Kidney Disease: A Patient Survey in China. Int J Nephrol Renovasc Dis 2021;14:53-64. [PMID: 33654421 DOI: 10.2147/IJNRD.S291393] [Reference Citation Analysis]
36 Hu X, Xie J, Chen N. Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia. Kidney Dis (Basel) 2021;7:1-9. [PMID: 33614728 DOI: 10.1159/000510587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Akizawa T, Okumura H, Alexandre AF, Fukushima A, Kiyabu G, Dorey J. Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review. Ther Apher Dial 2018;22:444-56. [PMID: 30022586 DOI: 10.1111/1744-9987.12712] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
38 George S, McCann M. A nurse prescriber-led protocol for anaemia management in established haemodialysis patients: A retrospective study. J Clin Nurs 2020;29:2535-43. [PMID: 32267027 DOI: 10.1111/jocn.15275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Lai C, Aceto P, Luciani M, Fazzari E, Cesari V, Luciano S, Fortini A, Berloco D, Canulla F, Bruzzese V, Lai S. Emotional management and biological markers of dietetic regimen in chronic kidney disease patients. Ren Fail 2017;39:173-8. [PMID: 27846784 DOI: 10.1080/0886022X.2016.1256312] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Brazzelli M, Aucott L, Aceves-Martins M, Robertson C, Jacobsen E, Imamura M, Poobalan A, Manson P, Scotland G, Kaye C, Sawhney S, Boyers D. Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis. Health Technol Assess 2022;26:1-286. [PMID: 35115079 DOI: 10.3310/UGEZ4120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]